El ciberespacio se encuentra en la red de ordenadores, en los teléfonos celulares, en los cajeros automáticos, en la tv digital del mundo. Es un término que proviene no del ingeniero de sistema o de un filosofar neopositivista, en donde los hechos están al margen del lenguaje, el sujeto y la cultura.
BACKGROUND:Physical activity alleviates menopausal symptoms in women whose menopause occurs after the age of 45; however, its effect in primary ovarian insufficiency, which occurs before the age of 40, remains unknown. OBJECTIVE:To examine the association between physical activity, menopausal symptoms, and the use of menopausal hormone therapy in women with primary ovarian insufficiency. METHODS:We analysed data from 4708 participants from two studies conducted in 12 Latin American countries. After applying eligibility criteria, 564 women with primary ovarian insufficiency (351 idiopathic and 213 surgical) were included. Menopausal symptoms were assessed using a validated scale, and severe symptoms were defined according to established cut-offs. Physical activity was classified according to international recommendations for moderate-intensity activity. Logistic regression models were adjusted for sociodemographic, clinical, and lifestyle variables. RESULTS:The prevalence of severe menopausal symptoms was 39.2%, with no significant difference between idiopathic and surgical primary ovarian insufficiency. Women with severe symptoms were less likely to meet recommended levels of physical activity or to be current users of menopausal hormone therapy. In adjusted models, regular physical activity (OR 0.65; 95% CI 0.45-0.94) and current use of menopausal hormone therapy (OR 0.27; 0.17-0.42) were associated with a lower likelihood of severe symptoms, whereas obesity and use of psychotropic medication were associated with a higher likelihood. CONCLUSIONS:Women with primary ovarian insufficiency who engage in regular physical activity or currently use menopausal hormone therapy report less severe menopausal symptoms. Regular exercise may be an important non-hormonal option for women who cannot or prefer not to use hormone therapy.
Hypertriglyceridemia-induced acute pancreatitis is associated with high triglyceride levels and may lead to significant clinical complications. Rapid TG-lowering strategies, including insulin, therapeutic plasma exchange (TPE), heparin, hemofiltration, and conservative management, are used in clinical practice; however, their comparative efficacy and impact on clinical outcomes remain uncertain. Following preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines and International Prospective Register of Systematic Reviews (PROSPERO) registration (CRD420251239674), we searched PubMed, Embase, Web of Science, Scopus, CINAHL, Google Scholar, and Cochrane. Primary outcomes included TG reduction, C-reactive protein (CRP), length of stay, mortality, and organ failure. Secondary outcomes included renal and respiratory failure. Random-effects network meta-analyses estimated mean differences or relative risks with 95
Background:Anemia is a common complication in chronic kidney disease (CKD), especially in hemodialysis patients, causing fatigue and reduced quality of life. Standard treatments involve iron and erythropoietin (EPO). Ascorbic acid (vitamin C) supports iron metabolism by converting ferric to ferrous iron and enhancing absorption and mobilization. This systematic review and meta-analysis evaluated the effectiveness of ascorbic acid in improving hematologic and iron parameters in adult anemic patients undergoing maintenance hemodialysis. Methods:Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive search was performed in PubMed, EMBASE, Cochrane, Scopus, Web of Science, CINAHL and Google Scholar through May 2025. Only randomized controlled trials and crossover studies assessing ascorbic acid in adult anemic hemodialysis patients were included. The protocol was registered in the International Prospective Register of Systematic Review (PROSPERO) (CRD420251056337). Primary outcomes were hemoglobin (Hb), ferritin, serum iron, transferrin saturation (TSAT) and total iron-binding capacity (TIBC). Meta-analyses used DerSimonian-Laird random-effects models. Results:Of 479 screened articles, 14 studies were included. Ascorbic acid supplementation was associated with a modest but significant increase in Hb [mean difference (MD) 0.94 g/dL; 95% confidence interval (CI) 0.57 to 1.31; P < .01; I² = 87.2%] and TSAT (MD 6.86%; 95% CI 1.93 to 11.78; P < .01; I² = 96.7%). Ferritin levels showed a slight but significant reduction (MD -65.00 ng/mL; 95% CI -117.20 to -12.80; P = .01; I² = 57.2%), along with a decrease in TIBC (MD -22.54 µg/dL; 95% CI -42.37 to -2.72; P = .03; I² = 76.1%). EPO requirements expressed as units/kg/week were significantly reduced (MD -21.29; 95% CI -27.73 to -14.84; P < .01; I² = 0.0%). No significant changes were observed in serum iron levels or EPO dosage expressed as IU/week. Conclusion:Ascorbic acid supplementation may confer modest hematologic benefits in hemodialysis patients with improvements in Hb, TSAT and iron utilization, and a small reduction in weight-adjusted erythropoiesis-stimulating agent dose. However, the certainty of evidence is low, and long-term safety and patient-centered outcomes remain unestablished.
Introducción: A finales de 2019 se reportó la enfermedad infecciosa por coronavirus (COVID-19), la cual se propagó globalmente, afectando a más de 600 millones de personas. A principios de 2020 se identificaron casos pediátricos con una presentación clínica inflamatoria asociada a COVID-19, denominados Síndrome Multisistémico Inflamatorio Pediátrico (MIS-C). Objetivo: Identificar las manifestaciones clínicas más frecuentes del MIS-C en pacientes atendidos en el Hospital Pediátrico Dr. Robert Reíd Cabral, Santo Domingo, República Dominicana, durante el período 2021–2022. Metodología: Estudio observacional, transversal, retrospectivo y analítico. Se recolectaron datos clínicos de 74 pacientes pediátricos con diagnóstico de MIS-C mediante un formulario estandarizado de la OMS. Se aplicó una prueba de Chi-cuadrado con un nivel de confianza del 95 % para evaluar la posible asociación entre marcadores inflamatorios séricos y los signos y síntomas clínicos. Para reducir sesgos, solo se analizaron los cinco signos y síntomas más frecuentes. Resultados: Las manifestaciones clínicas más comunes fueron fiebre (100 %), palidez cutánea (69 %) y exantema (49 %). El sexo masculino fue ligeramente más frecuente (51 %). El hallazgo radiográfico predominante fue cardiomegalia (10 %). El valor de p fue 0.99, indicando ausencia de asociación estadística significativa entre los marcadores inflamatorios y los signos y síntomas clínicos. El tratamiento más empleado fue el uso de antibióticos (85 %). Conclusiones: La fiebre, la palidez cutánea y el exantema fueron los signos clínicos más frecuentes del MIS-C. Predominó ligeramente el sexo masculino y el tratamiento más utilizado fue el soporte antibiótico.